Drug Makers Accused By Vietnam Agency Of Colluding On Prices
This article was originally published in PharmAsia News
Executive Summary
Vietnamese officials have accused domestic and foreign drug makers of colluding to fix the price of drugs at a price 200 to 300 times their cost. Representatives of the Competition Control Agency, an arm of the Ministry of Industry and Trade, said pharmaceutical companies, distributors and brokers set the price of drugs before they are imported into Vietnam. Distributors and importers in Vietnam say their prices are determined by the price set by foreign drug makers. The agency said firms also control the volume of drugs on the market so they can keep their prices high. (Click here for more
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.